Page 72 - AIDSBK23C
P. 72

Page 72


                       HIV Infection, Stage 1

                       No AIDS-defining condition and either CD4+ T-lymphocyte count of >500 cells/µL or
                       CD4+ T-lymphocyte percentage of total lymphocytes of >29.

                       HIV Infection, Stage 2

                       No AIDS-defining condition and either CD4+ T-lymphocyte count of 200--499 cells/µL
                       or CD4+ T-lymphocyte percentage of total lymphocytes of 14--28.

                       HIV Infection, Stage 3 (AIDS)

                       CD4+ T-lymphocyte count of <200 cells/µL or CD4+ T-lymphocyte percentage of total
                       lymphocytes of <14 or documentation of an AIDS-defining condition (see below).
                       Documentation of an AIDS-defining condition supersedes a CD4+ T-lymphocyte count
                       of >200 cells/µL and a CD4+ T-lymphocyte percentage of total lymphocytes of >14.
                       Definitive diagnostic methods for these conditions are shown below from the 1993
                       revised HIV classification system and the expanded AIDS case definition and from the
                       U.S. National Notifiable Diseases Surveillance System.

                       HIV Infection, Stage Unknown

                       No information available on CD4+ T-lymphocyte count or percentage and no information
                       available on AIDS-defining conditions. (Every effort should be made to report CD4+ T-
                       lymphocyte counts or percentages and the presence of AIDS-defining conditions at the
                       time of diagnosis.)


               A diagnosis of acute HIV infection indicates documented evidence of detectable HIV RNA or
               DNA or of p24 antigen in plasma or serum in the presence of a documented negative or
               indeterminate result from an HIV antibody test. These laboratory tests should be conducted on
               the same specimen or on specimens obtained on the same day. Acute HIV infection occurs
               approximately during the time from viral acquisition until seroconversion (i.e., the development
               of measurable levels of HIV-specific antibodies). During this period, early immune responses to
               the virus produce distinctive characteristics; 40% to 80% of patients develop clinical symptoms
               of a nonspecific viral illness (e.g., fever, fatigue, or rash) typically lasting 1--2 weeks.


               2008 Surveillance Case Definition for HIV Infection Among Children Aged <18 Months

                       The 2008 definition takes into account new available testing technologies. Because
                       diagnostic laboratory testing for HIV infection among children aged <18 months might
                       be unreliable, children in this age group with perinatal HIV exposure whose illness meets
                       the AIDS case definition on the basis of clinical criteria are considered presumptively
                       HIV infected when the mother has laboratory-confirmed HIV infection. The definitive or
                       presumptive exclusion of HIV infection for surveillance purposes does not mean that
   67   68   69   70   71   72   73   74   75   76   77